Ribomic, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−24 JPY
−1.02 B JPY
2.11 M JPY
51.61 M
About Ribomic, Inc.
Sector
Industry
Website
Headquarters
Tokyo
Founded
2003
IPO date
Sep 25, 2014
IPO offer price
21.46 USD
Identifiers
2
ISINJP3974850004
RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. It utilizes the Ribomic Aptamer Therapeutics (RiboART) system to discover new drugs that are applicable to target proteins. The company was founded by Yoshikazu Nakamura on August 1, 2003 and is headquartered in Tokyo, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4591 is 78 JPY — it has increased by 1.30% in the past 24 hours. Watch Ribomic, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Ribomic, Inc. stocks are traded under the ticker 4591.
4591 stock has risen by 5.41% compared to the previous week, the month change is a −7.14% fall, over the last year Ribomic, Inc. has showed a −2.50% decrease.
4591 reached its all-time high on Sep 25, 2014 with the price of 2,078 JPY, and its all-time low was 60 JPY and was reached on Aug 5, 2024. View more price dynamics on 4591 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4591 stock is 4.00% volatile and has beta coefficient of 0.61. Track Ribomic, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ribomic, Inc. there?
Today Ribomic, Inc. has the market capitalization of 4.24 B, it has decreased by −6.03% over the last week.
Yes, you can track Ribomic, Inc. financials in yearly and quarterly reports right on TradingView.
Ribomic, Inc. is going to release the next earnings report on Feb 6, 2026. Keep track of upcoming events with our Earnings Calendar.
4591 net income for the last quarter is −286.72 M JPY, while the quarter before that showed −227.45 M JPY of net income which accounts for −26.06% change. Track more Ribomic, Inc. financial stats to get the full picture.
No, 4591 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 4, 2026, the company has 25 employees. See our rating of the largest employees — is Ribomic, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ribomic, Inc. EBITDA is −1.07 B JPY, and current EBITDA margin is −49.82 K%. See more stats in Ribomic, Inc. financial statements.
Like other stocks, 4591 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ribomic, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ribomic, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ribomic, Inc. stock shows the strong sell signal. See more of Ribomic, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.